Sanofi India Limited Receives an Order Passed by the Office of the Assistant Commissioner of State Tax, State Goods and Services Tax Department, Taxpayer Services Circle Kadavanthra At Tripunithura
May 06, 2024 at 03:01 am
Share
Sanofi India Limited announced an order passed by the Office of the Assistant Commissioner of State Tax, State Goods and Services Tax Department, Taxpayer Services Circle Kadavanthra at Tripunithura. Nature and details of the action(s) taken, initiated or order(s) passed: Order imposing a penalty of INR 9.99 Million for the non-issuance of e-way bills. Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority: 29th April 2024. Details of the violation(s)/contravention(s) committed or alleged to be committed; The Company has been issued a penalty order for INR 9.99 million by the Assistant Commissioner of State Tax under the CGST/SGST Act 2017. The penalty is for failing to issue e-way bills for goods valued over INR 50,000. Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible: There is no material impact on financial, operation or other activities of the Company due to the order passed by the Office of the Assistant Commissioner. As the Order is currently subject to appeal, the Company will make an assessment to exercise its right to appeal. Explanation(s) for delay in disclosure: The Company was reviewing the order with the
consultant and assessing the next steps in the matter.
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
Sanofi India Limited Receives an Order Passed by the Office of the Assistant Commissioner of State Tax, State Goods and Services Tax Department, Taxpayer Services Circle Kadavanthra At Tripunithura
SANOFI INDIA LIMITED 
